Selective inhibition of endothelial cell proliferation by fumagillin is, not due to differential expression of methionine aminopeptidases

Journal of Cellular Biochemistry

Volumn 77, Issue 3, 2000, Pages 465-473

  Wang, Jieyi ^a   Lou, Pingping ^a   Henkin, Jack ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Angiogenesis; Endothelial cells; Fumagillin; MetAP2; Methionine aminopeptidase; p67; TNP 470

Indexed keywords

AMINOPEPTIDASE; ANGIOGENESIS INHIBITOR; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; METHIONYL AMINOPEPTIDASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION;

AMINOPEPTIDASES; ANTI-BACTERIAL AGENTS; CELL DIVISION; CELLS, CULTURED; CYCLOHEXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FATTY ACIDS, UNSATURATED; HUMANS; IMMUNOBLOTTING; METALLOENDOPEPTIDASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES; TIME FACTORS;

TRIXIS;

EID: 0034054364     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000601)77:3<465::AID-JCB11>3.0.CO;2-M     Document Type: Article

References (24)

1. Abe J, Zhou W, Takuwa N, Taguchi J, Kurokawa K, Kumada M, Takuwa Y. 1994. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res 54:3407-3412.
2. Arfin SM, Kendall RL, Hall L, Weaver LH, Stewart AE, Matthews BW, Bradshaw RA. 1995. Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. Proc Natl Acad Sci USA 92:7714-7718.
3. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. 1999. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284:808-812.
4. Bradshaw RA, Brickey WW, Walker K.W. 1998. N-terminal processing: the methionine aminopeptidase and Nα-acetyl transferase families. Trends Biochem Sci 23:263-267.
5. Castronovo V, Belotti D. 1996. TNP-470 (AGM-1470): mechanisms of action and early clinical development [review]. Eur J Cancer 32A:2520-2527.
6. Datta B, Datta R. 1999. Induction of apoptosis due to lowering the level of eukaryotic initiation factor 2-associated protein, p67, from mammalian cells by antisense approach. Exp Cell Res 246:376-383.
7. Datta B, Chakrabarti D, Roy AL, Gupta NK. 1988. Roles of a 67-kDa polypeptide in reversal of protein synthesis inhibition in heme-deficient reticulocyte lysate. Proc Natl Acad Sci USA 85:3324-3328.
8. Folkman J. 1995. Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763.
9. Gervaz P, Fontolliet C. 1998. Therapeutic potential of the anti-angiogenesis drug TNP-470. Int J Exp Pathol 79: 359-362.
10. Griffith EC, Su Z, Turk BE, Chen S, Chang YH, Wu Z, Biemann K Liu JO. 1997. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol 4:461-471.
11. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J. 1990. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555-557.
12. Killough JH, Magill GB, Amith RC. 1952. The treatment of amebiasis with fumagillin. Science 115:71-72.
13. Kudelka AP, Verschraegen CF, Loyer E. 1998. Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470 [letter]. N Engl J Med 338: 991-992.
14. Kusaka M, Sudo K, Matsutani E, Kozai Y, Marui S, Fujita T, Ingber D, Folkman J. 1994. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer 69:212-216.
15. Li X, Chang, Y.-H. 1995a. Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. Proc Natl Acad Sci USA 92:12357-12361.
16. Li X Chang Y-H. 1995b. Molecular cloning of a human complementary DNA encoding an initiation factor 2-associated protein (p67). Biochim Biophys Acta 1260: 333-336.
17. Liu S, Widom J, Kemp CW, Crews CM, Clardy J. 1998. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science 282:1324-1327.
18. Lowther WT, McMillen DA, Orville AM, Matthews BW. 1998. The anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidase. Proc Natl Acad Sci USA 95:12153-12157.
19. Ray MK, Datta B, Chakraborty A, Chattopadhyay A, Meza-Keuthen S, Gupta NK. 1992. The eukaryotic initiation factor 2-associated 67-kDa polypeptide (p67) plays a critical role in regulation of protein synthesis initiation in animal cells. Proc Natl Acad Sci USA 89:539-543.
20. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM. 1997. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci USA 94:6099-6103.
21. Wu S, Gupta S, Chatterjee N, Hileman RE, Kinzy TG, Denslow ND, Merrick WC, Chakrabarti D, Osterman JC, Gupta NK. 1993. Cloning and characterization of complementary DNA encoding the eukaryotic initiation factor 2-associated 67-kDa protein (p67). J Biol Chem 268: 10796-10781.
22. Yamamoto T, Sudo K Fujita T. 1994. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res 14:1-3.
23. Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K, Fujita T. 1993. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res 53:4262-4267.
24. Yancopoulos GD, Klagsbrun M, Folkman J. 1998. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 93:661-664.